Somatostatin-Immunoreactive Pancreaticoduodenal Neuroendocrine Neoplasms: Twenty-Three Cases Evaluated according to the WHO 2010 Classification

Publisher： Karger

E-ISSN： 1423-0194|103|5|567-577

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.103, Iss.5, 2015-10, pp. : 567-577

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Novel WHO 2010 Classification for Gastrointestinal Neuroendocrine Tumours Correlates Well with the Metastatic Potential of Rectal Neuroendocrine Tumours

By  

Neuroendocrinology, Vol. 95, Iss. 4, 2012-02 ,pp. : 317-324

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues

By  

Neuroendocrinology, Vol. 105, Iss. 3, 2017-04 ,pp. : 295-309

Karger

Access to resources Recommend Favorite

Thymic Neuroendocrine Neoplasms: Biological Behaviour and Therapy

By  

Neuroendocrinology, Vol. 105, Iss. 2, 2017-03 ,pp. : 105-114

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms

By  

Neuroendocrinology, Vol. 103, Iss. 2, 2016-01 ,pp. : 139-143

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

By  

Neuroendocrinology, Vol. 103, Iss. 2, 2016-01 ,pp. : 119-124

Karger

Access to resources Recommend Favorite